Report Detail

Pharma & Healthcare Global (United States, European Union and China) Celiac Disease Drug Market Research Report 2019-2025

  • RnM3333968
  • |
  • 21 April, 2019
  • |
  • Global
  • |
  • 127 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

In 2019, the market size of Celiac Disease Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Celiac Disease Drug.

This report studies the global market size of Celiac Disease Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Celiac Disease Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Takeda Pharmaceutical
Novartis
LFB Group
Kedrion Biopharma

Market Segment by Product Type
Distension
Diarrhea
Anorexia
Others

Market Segment by Application
First line of treatment
Second line of treatment

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Celiac Disease Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Celiac Disease Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Celiac Disease Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Celiac Disease Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Distension
      • 1.3.3 Diarrhea
      • 1.3.4 Anorexia
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Celiac Disease Drug Market Share by Application (2019-2025)
      • 1.4.2 First line of treatment
      • 1.4.3 Second line of treatment
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Celiac Disease Drug Market Size
      • 2.1.1 Global Celiac Disease Drug Revenue 2014-2025
      • 2.1.2 Global Celiac Disease Drug Sales 2014-2025
    • 2.2 Celiac Disease Drug Growth Rate by Regions
      • 2.2.1 Global Celiac Disease Drug Sales by Regions 2014-2019
      • 2.2.2 Global Celiac Disease Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Celiac Disease Drug Sales by Manufacturers
      • 3.1.1 Celiac Disease Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Celiac Disease Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Celiac Disease Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Celiac Disease Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Celiac Disease Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Celiac Disease Drug Price by Manufacturers
    • 3.4 Key Manufacturers Celiac Disease Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Celiac Disease Drug Market
    • 3.6 Key Manufacturers Celiac Disease Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Distension Sales and Revenue (2014-2019)
      • 4.1.2 Diarrhea Sales and Revenue (2014-2019)
      • 4.1.3 Anorexia Sales and Revenue (2014-2019)
      • 4.1.4 Others Sales and Revenue (2014-2019)
    • 4.2 Global Celiac Disease Drug Sales Market Share by Type
    • 4.3 Global Celiac Disease Drug Revenue Market Share by Type
    • 4.4 Celiac Disease Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Celiac Disease Drug Sales by Application

    6 United States

    • 6.1 United States Celiac Disease Drug Breakdown Data by Company
    • 6.2 United States Celiac Disease Drug Breakdown Data by Type
    • 6.3 United States Celiac Disease Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Celiac Disease Drug Breakdown Data by Company
    • 7.2 European Union Celiac Disease Drug Breakdown Data by Type
    • 7.3 European Union Celiac Disease Drug Breakdown Data by Application

    8 China

    • 8.1 China Celiac Disease Drug Breakdown Data by Company
    • 8.2 China Celiac Disease Drug Breakdown Data by Type
    • 8.3 China Celiac Disease Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Celiac Disease Drug Breakdown Data by Company
    • 9.2 Rest of World Celiac Disease Drug Breakdown Data by Type
    • 9.3 Rest of World Celiac Disease Drug Breakdown Data by Application
    • 9.4 Rest of World Celiac Disease Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Celiac Disease Drug Sales by Countries
      • 9.4.2 Rest of World Celiac Disease Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 F. Hoffmann-La Roche
      • 10.1.1 F. Hoffmann-La Roche Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.1.4 Celiac Disease Drug Product Introduction
      • 10.1.5 F. Hoffmann-La Roche Recent Development
    • 10.2 Johnson & Johnson
      • 10.2.1 Johnson & Johnson Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.2.4 Celiac Disease Drug Product Introduction
      • 10.2.5 Johnson & Johnson Recent Development
    • 10.3 Merck
      • 10.3.1 Merck Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.3.4 Celiac Disease Drug Product Introduction
      • 10.3.5 Merck Recent Development
    • 10.4 Pfizer
      • 10.4.1 Pfizer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.4.4 Celiac Disease Drug Product Introduction
      • 10.4.5 Pfizer Recent Development
    • 10.5 ADMA Biologics
      • 10.5.1 ADMA Biologics Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.5.4 Celiac Disease Drug Product Introduction
      • 10.5.5 ADMA Biologics Recent Development
    • 10.6 Amgen
      • 10.6.1 Amgen Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.6.4 Celiac Disease Drug Product Introduction
      • 10.6.5 Amgen Recent Development
    • 10.7 Anthera Pharmaceuticals
      • 10.7.1 Anthera Pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.7.4 Celiac Disease Drug Product Introduction
      • 10.7.5 Anthera Pharmaceuticals Recent Development
    • 10.8 Bayer
      • 10.8.1 Bayer Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.8.4 Celiac Disease Drug Product Introduction
      • 10.8.5 Bayer Recent Development
    • 10.9 Biogen
      • 10.9.1 Biogen Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.9.4 Celiac Disease Drug Product Introduction
      • 10.9.5 Biogen Recent Development
    • 10.10 BioLineRx
      • 10.10.1 BioLineRx Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Celiac Disease Drug
      • 10.10.4 Celiac Disease Drug Product Introduction
      • 10.10.5 BioLineRx Recent Development
    • 10.11 Biotest
    • 10.12 Bristol-Myers Squibb
    • 10.13 Celgene
    • 10.14 Takeda Pharmaceutical
    • 10.15 Novartis
    • 10.16 LFB Group
    • 10.17 Kedrion Biopharma

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Celiac Disease Drug Sales Channels
      • 11.2.2 Celiac Disease Drug Distributors
    • 11.3 Celiac Disease Drug Customers

    12 Market Forecast

    • 12.1 Global Celiac Disease Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Celiac Disease Drug Sales Forecast by Type
    • 12.3 Global Celiac Disease Drug Sales Forecast by Application
    • 12.4 Celiac Disease Drug Forecast by Regions
      • 12.4.1 Global Celiac Disease Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Celiac Disease Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Celiac Disease Drug. Industry analysis & Market Report on Celiac Disease Drug is a syndicated market report, published as Global (United States, European Union and China) Celiac Disease Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Celiac Disease Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,597.76
      3,896.64
      5,195.52
      3,037.28
      4,555.92
      6,074.56
      496,428.00
      744,642.00
      992,856.00
      273,552.00
      410,328.00
      547,104.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report